Oct 23, 2018
The Drug Discovery and Development (DDD) process continues to slowly evolve to address the perpetual problem of the complexity and uniqueness of human metabolism and physiology.
More recently with the advent of personalised medicine and precision medicine, there have been efforts made to address this individual complexity. An understanding of personalised medicine versus precision medicine is necessary in order to understand such endeavours.
This has led to the development of what have been labelled ‘Targeted’ or ‘Personalised Medicine Drugs’. Based on the differences between the N-of-1 model (personalised medicine) and the 1-in-N model (precision medicine), this episode proposes that a more appropriate name is ‘Precision Medicine Drugs’, and we will be discussing precision medicine further in this episode.
Original article by Dr Urban Kiernan and Dr Stephen Naylor
If you'd like to view the original article then follow the link below:
You can also download the original article pdf here:
For more information on Drug Discovery World, head to: